J&K&L High Court: Transfer Guidelines are Not Binding and Cannot Limit an Employer’s Transfer Powers  ||  Calcutta High Court: Procedural Delays Cannot Deny a Person’s Right to Adopt  ||  J&K&L HC: Pardoned Approver under Section 343 BNSS Need Not Stay in Custody Till Trial Ends  ||  J&K&L HC: Accused Cannot Demand Charges under a Preferred Law When Acts Fall under Multiple Statutes  ||  J&K&L HC: Accused Cannot Demand Charges under a Preferred Law When Acts Fall under Multiple Statutes  ||  Allahabad HC: Civil Imprisonment For Default Does Not Absolve a Husband’s Duty to Pay Maintenance  ||  Supreme Court: SC Status Applies Only to Hindus, Sikhs, and Buddhists, and is Lost on Conversion  ||  Supreme Court: Post-Moratorium, Creditors Cannot Adjust Pre-CIRP Dues From Prior Deposits  ||  Supreme Court: CoC’s Commercial Wisdom Does Not Shield All its Decisions From Judicial Scrutiny  ||  SC Flags Systemic Bias in Granting Permanent Commission to Women Officers in Armed Forces    

Glenmark Settles Patent Litigation over Milnacipran Hydrochloride Tablets - (22 Dec 2015)

Glenmark Pharmaceuticals Inc., USA have entered into a settlement agreement with Forest Laboratories, LLC, Forest Laboratories Holdings, and Royalty Pharma Collection Trust to settle and dismissed outstanding patent litigation related to Glenmark's Abbreviated New Drug Application.

Tags : GLENMARK PHARMACEUTICALS INC   FOREST LABORATORIES   LLC   FOREST LABORATORIES HOLDINGS     ROYALTY PHARMA COLLECTION TRUST  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved